Global Liquid Biopsy Diagnostic Tool Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI07242171

Publication Date:

July 2, 2024

Pages:

126

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Liquid Biopsy Diagnostic Tool market size was valued at US$ 1296.2 million in 2023. With growing demand in downstream market, the Liquid Biopsy Diagnostic Tool is forecast to a readjusted size of US$ 4821.7 million by 2030 with a CAGR of 20.6% during review period.
The research report highlights the growth potential of the global Liquid Biopsy Diagnostic Tool market. Liquid Biopsy Diagnostic Tool are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Liquid Biopsy Diagnostic Tool. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Liquid Biopsy Diagnostic Tool market.
Liquid Biopsy Diagnostic Tool is a medical device or technology that analyzes various biomarkers present in bodily fluids, such as blood, to detect diseases like cancer or other health conditions. It offers a less invasive alternative to traditional tissue biopsies.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Liquid Biopsy Diagnostic Tool market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Liquid Biopsy Diagnostic Tool market. It may include historical data, market segmentation by Type (e.g., Instrument, Reagent), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Liquid Biopsy Diagnostic Tool market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Liquid Biopsy Diagnostic Tool market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Liquid Biopsy Diagnostic Tool industry. This include advancements in Liquid Biopsy Diagnostic Tool technology, Liquid Biopsy Diagnostic Tool new entrants, Liquid Biopsy Diagnostic Tool new investment, and other innovations that are shaping the future of Liquid Biopsy Diagnostic Tool.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Liquid Biopsy Diagnostic Tool market. It includes factors influencing customer ' purchasing decisions, preferences for Liquid Biopsy Diagnostic Tool product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Liquid Biopsy Diagnostic Tool market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Liquid Biopsy Diagnostic Tool market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Liquid Biopsy Diagnostic Tool market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Liquid Biopsy Diagnostic Tool industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Liquid Biopsy Diagnostic Tool market.
Market Segmentation:
Liquid Biopsy Diagnostic Tool market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Instrument
Reagent
Others
Segmentation by application
Hospital
Third-party Testing Agency
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Biocept
Qiagen
Roche Diagnostics
Bio-Rad Laboratories
Myriad Genetics
Menarini-Silicon Biosystems
Trovagene
Guardant Health
Mdxhealth
Genomic Health
Raindance Technologies
Thermo Fisher Scientific
Illumina
Amoy Diagnostics
Johnson & Johnson

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Liquid Biopsy Diagnostic Tool Market Size 2019-2030
2.1.2 Liquid Biopsy Diagnostic Tool Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Liquid Biopsy Diagnostic Tool Segment by Type
2.2.1 Instrument
2.2.2 Reagent
2.2.3 Others
2.3 Liquid Biopsy Diagnostic Tool Market Size by Type
2.3.1 Liquid Biopsy Diagnostic Tool Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Liquid Biopsy Diagnostic Tool Market Size Market Share by Type (2019-2024)
2.4 Liquid Biopsy Diagnostic Tool Segment by Application
2.4.1 Hospital
2.4.2 Third-party Testing Agency
2.5 Liquid Biopsy Diagnostic Tool Market Size by Application
2.5.1 Liquid Biopsy Diagnostic Tool Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Liquid Biopsy Diagnostic Tool Market Size Market Share by Application (2019-2024)
3 Liquid Biopsy Diagnostic Tool Market Size by Player
3.1 Liquid Biopsy Diagnostic Tool Market Size Market Share by Players
3.1.1 Global Liquid Biopsy Diagnostic Tool Revenue by Players (2019-2024)
3.1.2 Global Liquid Biopsy Diagnostic Tool Revenue Market Share by Players (2019-2024)
3.2 Global Liquid Biopsy Diagnostic Tool Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Liquid Biopsy Diagnostic Tool by Regions
4.1 Liquid Biopsy Diagnostic Tool Market Size by Regions (2019-2024)
4.2 Americas Liquid Biopsy Diagnostic Tool Market Size Growth (2019-2024)
4.3 APAC Liquid Biopsy Diagnostic Tool Market Size Growth (2019-2024)
4.4 Europe Liquid Biopsy Diagnostic Tool Market Size Growth (2019-2024)
4.5 Middle East & Africa Liquid Biopsy Diagnostic Tool Market Size Growth (2019-2024)
5 Americas
5.1 Americas Liquid Biopsy Diagnostic Tool Market Size by Country (2019-2024)
5.2 Americas Liquid Biopsy Diagnostic Tool Market Size by Type (2019-2024)
5.3 Americas Liquid Biopsy Diagnostic Tool Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Liquid Biopsy Diagnostic Tool Market Size by Region (2019-2024)
6.2 APAC Liquid Biopsy Diagnostic Tool Market Size by Type (2019-2024)
6.3 APAC Liquid Biopsy Diagnostic Tool Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Liquid Biopsy Diagnostic Tool by Country (2019-2024)
7.2 Europe Liquid Biopsy Diagnostic Tool Market Size by Type (2019-2024)
7.3 Europe Liquid Biopsy Diagnostic Tool Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Liquid Biopsy Diagnostic Tool by Region (2019-2024)
8.2 Middle East & Africa Liquid Biopsy Diagnostic Tool Market Size by Type (2019-2024)
8.3 Middle East & Africa Liquid Biopsy Diagnostic Tool Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Liquid Biopsy Diagnostic Tool Market Forecast
10.1 Global Liquid Biopsy Diagnostic Tool Forecast by Regions (2025-2030)
10.1.1 Global Liquid Biopsy Diagnostic Tool Forecast by Regions (2025-2030)
10.1.2 Americas Liquid Biopsy Diagnostic Tool Forecast
10.1.3 APAC Liquid Biopsy Diagnostic Tool Forecast
10.1.4 Europe Liquid Biopsy Diagnostic Tool Forecast
10.1.5 Middle East & Africa Liquid Biopsy Diagnostic Tool Forecast
10.2 Americas Liquid Biopsy Diagnostic Tool Forecast by Country (2025-2030)
10.2.1 United States Liquid Biopsy Diagnostic Tool Market Forecast
10.2.2 Canada Liquid Biopsy Diagnostic Tool Market Forecast
10.2.3 Mexico Liquid Biopsy Diagnostic Tool Market Forecast
10.2.4 Brazil Liquid Biopsy Diagnostic Tool Market Forecast
10.3 APAC Liquid Biopsy Diagnostic Tool Forecast by Region (2025-2030)
10.3.1 China Liquid Biopsy Diagnostic Tool Market Forecast
10.3.2 Japan Liquid Biopsy Diagnostic Tool Market Forecast
10.3.3 Korea Liquid Biopsy Diagnostic Tool Market Forecast
10.3.4 Southeast Asia Liquid Biopsy Diagnostic Tool Market Forecast
10.3.5 India Liquid Biopsy Diagnostic Tool Market Forecast
10.3.6 Australia Liquid Biopsy Diagnostic Tool Market Forecast
10.4 Europe Liquid Biopsy Diagnostic Tool Forecast by Country (2025-2030)
10.4.1 Germany Liquid Biopsy Diagnostic Tool Market Forecast
10.4.2 France Liquid Biopsy Diagnostic Tool Market Forecast
10.4.3 UK Liquid Biopsy Diagnostic Tool Market Forecast
10.4.4 Italy Liquid Biopsy Diagnostic Tool Market Forecast
10.4.5 Russia Liquid Biopsy Diagnostic Tool Market Forecast
10.5 Middle East & Africa Liquid Biopsy Diagnostic Tool Forecast by Region (2025-2030)
10.5.1 Egypt Liquid Biopsy Diagnostic Tool Market Forecast
10.5.2 South Africa Liquid Biopsy Diagnostic Tool Market Forecast
10.5.3 Israel Liquid Biopsy Diagnostic Tool Market Forecast
10.5.4 Turkey Liquid Biopsy Diagnostic Tool Market Forecast
10.5.5 GCC Countries Liquid Biopsy Diagnostic Tool Market Forecast
10.6 Global Liquid Biopsy Diagnostic Tool Forecast by Type (2025-2030)
10.7 Global Liquid Biopsy Diagnostic Tool Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Biocept
11.1.1 Biocept Company Information
11.1.2 Biocept Liquid Biopsy Diagnostic Tool Product Offered
11.1.3 Biocept Liquid Biopsy Diagnostic Tool Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Biocept Main Business Overview
11.1.5 Biocept Latest Developments
11.2 Qiagen
11.2.1 Qiagen Company Information
11.2.2 Qiagen Liquid Biopsy Diagnostic Tool Product Offered
11.2.3 Qiagen Liquid Biopsy Diagnostic Tool Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Qiagen Main Business Overview
11.2.5 Qiagen Latest Developments
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Company Information
11.3.2 Roche Diagnostics Liquid Biopsy Diagnostic Tool Product Offered
11.3.3 Roche Diagnostics Liquid Biopsy Diagnostic Tool Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Roche Diagnostics Main Business Overview
11.3.5 Roche Diagnostics Latest Developments
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Information
11.4.2 Bio-Rad Laboratories Liquid Biopsy Diagnostic Tool Product Offered
11.4.3 Bio-Rad Laboratories Liquid Biopsy Diagnostic Tool Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Bio-Rad Laboratories Main Business Overview
11.4.5 Bio-Rad Laboratories Latest Developments
11.5 Myriad Genetics
11.5.1 Myriad Genetics Company Information
11.5.2 Myriad Genetics Liquid Biopsy Diagnostic Tool Product Offered
11.5.3 Myriad Genetics Liquid Biopsy Diagnostic Tool Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Myriad Genetics Main Business Overview
11.5.5 Myriad Genetics Latest Developments
11.6 Menarini-Silicon Biosystems
11.6.1 Menarini-Silicon Biosystems Company Information
11.6.2 Menarini-Silicon Biosystems Liquid Biopsy Diagnostic Tool Product Offered
11.6.3 Menarini-Silicon Biosystems Liquid Biopsy Diagnostic Tool Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Menarini-Silicon Biosystems Main Business Overview
11.6.5 Menarini-Silicon Biosystems Latest Developments
11.7 Trovagene
11.7.1 Trovagene Company Information
11.7.2 Trovagene Liquid Biopsy Diagnostic Tool Product Offered
11.7.3 Trovagene Liquid Biopsy Diagnostic Tool Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Trovagene Main Business Overview
11.7.5 Trovagene Latest Developments
11.8 Guardant Health
11.8.1 Guardant Health Company Information
11.8.2 Guardant Health Liquid Biopsy Diagnostic Tool Product Offered
11.8.3 Guardant Health Liquid Biopsy Diagnostic Tool Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Guardant Health Main Business Overview
11.8.5 Guardant Health Latest Developments
11.9 Mdxhealth
11.9.1 Mdxhealth Company Information
11.9.2 Mdxhealth Liquid Biopsy Diagnostic Tool Product Offered
11.9.3 Mdxhealth Liquid Biopsy Diagnostic Tool Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Mdxhealth Main Business Overview
11.9.5 Mdxhealth Latest Developments
11.10 Genomic Health
11.10.1 Genomic Health Company Information
11.10.2 Genomic Health Liquid Biopsy Diagnostic Tool Product Offered
11.10.3 Genomic Health Liquid Biopsy Diagnostic Tool Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Genomic Health Main Business Overview
11.10.5 Genomic Health Latest Developments
11.11 Raindance Technologies
11.11.1 Raindance Technologies Company Information
11.11.2 Raindance Technologies Liquid Biopsy Diagnostic Tool Product Offered
11.11.3 Raindance Technologies Liquid Biopsy Diagnostic Tool Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Raindance Technologies Main Business Overview
11.11.5 Raindance Technologies Latest Developments
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Company Information
11.12.2 Thermo Fisher Scientific Liquid Biopsy Diagnostic Tool Product Offered
11.12.3 Thermo Fisher Scientific Liquid Biopsy Diagnostic Tool Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Thermo Fisher Scientific Main Business Overview
11.12.5 Thermo Fisher Scientific Latest Developments
11.13 Illumina
11.13.1 Illumina Company Information
11.13.2 Illumina Liquid Biopsy Diagnostic Tool Product Offered
11.13.3 Illumina Liquid Biopsy Diagnostic Tool Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Illumina Main Business Overview
11.13.5 Illumina Latest Developments
11.14 Amoy Diagnostics
11.14.1 Amoy Diagnostics Company Information
11.14.2 Amoy Diagnostics Liquid Biopsy Diagnostic Tool Product Offered
11.14.3 Amoy Diagnostics Liquid Biopsy Diagnostic Tool Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Amoy Diagnostics Main Business Overview
11.14.5 Amoy Diagnostics Latest Developments
11.15 Johnson & Johnson
11.15.1 Johnson & Johnson Company Information
11.15.2 Johnson & Johnson Liquid Biopsy Diagnostic Tool Product Offered
11.15.3 Johnson & Johnson Liquid Biopsy Diagnostic Tool Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Johnson & Johnson Main Business Overview
11.15.5 Johnson & Johnson Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂